SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-011986
Filing Date
2022-05-04
Accepted
2022-05-04 06:05:19
Documents
13
Period of Report
2022-05-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34839
2 ex99-1.htm EX-99.1 21637
  Complete submission text file 0001493152-22-011986.txt   230454

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qnta-20220504.xsd EX-101.SCH 3039
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qnta-20220504_lab.xml EX-101.LAB 34476
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qnta-20220504_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3352
Mailing Address 632 S GLENWOOD PL BURBANK CA 91506
Business Address 632 S GLENWOOD PL BURBANK CA 91506 (818) 940-1617
QUANTA INC (Filer) CIK: 0001691430 (see all company filings)

IRS No.: 812749032 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56025 | Film No.: 22889690
SIC: 2833 Medicinal Chemicals & Botanical Products